scholarly article | Q13442814 |
P356 | DOI | 10.1038/NM0197-73 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/nm0197-73 |
P698 | PubMed publication ID | 8986744 |
P50 | author | Jacqueline Bresnahan | Q67524117 |
P2093 | author name string | M S Beattie | |
M J Crowe | |||
J N Masters | |||
S L Shuman | |||
P2860 | cites work | Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation | Q24642901 |
An electron-microscopic analysis of axonal alterations following blunt contusion of the spinal cord of the rhesus monkey (Macaca mulatta) | Q31913872 | ||
Does oligodendrocyte survival depend on axons? | Q34344083 | ||
Spinal cord injury models: neurophysiology | Q35393660 | ||
Importance of pharmacologic considerations in the evaluation of new treatments for acute spinal cord injury | Q35393775 | ||
Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. | Q36437643 | ||
Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia. | Q40369886 | ||
Programmed cell death and the control of cell survival: lessons from the nervous system | Q40777905 | ||
Neuronal apoptosis: current understanding of molecular mechanisms and potential role in ischemic brain injury | Q40965347 | ||
CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. | Q46020332 | ||
Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. | Q47331040 | ||
Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord | Q48129257 | ||
The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. | Q54179139 | ||
Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. | Q55480343 | ||
A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury | Q56775114 | ||
Expression of the APC tumor suppressor protein in oligodendroglia | Q58414677 | ||
A neuroanatomical analysis of spinal cord injury in the rhesus monkey (Macaca mulatta) | Q67524121 | ||
Apoptosis and expression of Bcl-2 after compression trauma to rat spinal cord | Q71483698 | ||
Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats | Q71959419 | ||
Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death | Q72549763 | ||
In situ demonstration of mature oligodendrocytes and their processes: an immunocytochemical study with a new monoclonal antibody, rip | Q93524085 | ||
P433 | issue | 1 | |
P921 | main subject | apoptotic process | Q14599311 |
P304 | page(s) | 73-76 | |
P577 | publication date | 1997-01-01 | |
P1433 | published in | Nature Medicine | Q1633234 |
P1476 | title | Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys | |
P478 | volume | 3 |
Q37595313 | 17β-estradiol protects human eyelid-derived adipose stem cells against cytotoxicity and increases transplanted cell survival in spinal cord injury |
Q48319077 | 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion |
Q43558063 | 4-Hydroxynonenal, a lipid peroxidation byproduct of spinal cord injury, is cytotoxic for oligodendrocyte progenitors and inhibits their responsiveness to PDGF. |
Q92749168 | A Bibliometric Analysis of Publications on Spinal Cord Injury During 1980-2018 |
Q36123720 | A Coral-Derived Compound Improves Functional Recovery after Spinal Cord Injury through Its Antiapoptotic and Anti-Inflammatory Effects. |
Q37381737 | A gastric hormone to treat spinal cord injury? |
Q48382942 | A preclinical model of hyperalgesia following spinal stenosis/compression |
Q37263197 | Aberrant LncRNA Expression Profile in a Contusion Spinal Cord Injury Mouse Model |
Q78060140 | Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury |
Q97516678 | Acute Cellular and Functional Changes With a Combinatorial Treatment of Ion Channel Inhibitors Following Spinal Cord Injury |
Q35740049 | Acute and prolonged hindlimb exercise elicits different gene expression in motoneurons than sensory neurons after spinal cord injury |
Q42183946 | Acute traumatic spinal cord injury induces glial activation in the cynomolgus macaque (Macaca fascicularis). |
Q46515755 | Adenosine modulates excitatory synaptic transmission and suppresses neuronal death induced by ischaemia in rat spinal motoneurones |
Q48167359 | Administration of prosaposin ameliorates spatial learning disturbance and reduces cavity formation following stab wounds in rat brain. |
Q48479802 | Akhirin regulates the proliferation and differentiation of neural stem cells in intact and injured mouse spinal cord. |
Q59468445 | Alterations in AMPA receptor subunit expression after experimental spinal cord contusion injury |
Q39205118 | Altered apoptotic responses in neurons lacking RhoB GTPase |
Q33606808 | Altered microRNA expression following traumatic spinal cord injury |
Q36573390 | An Up-regulation of IRF-1 After a Spinal Cord Injury: Implications for Neuronal Apoptosis |
Q44051046 | An ανβ3 integrin-binding peptide ameliorates symptoms of chronic progressive experimental autoimmune encephalomyelitis by alleviating neuroinflammatory responses in mice |
Q28475604 | Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recovery |
Q73713217 | Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3 |
Q35944010 | Animal models of optic nerve diseases |
Q37417730 | Antineuroinflammatory and neurotrophic effects of CNTF and C16 peptide in an acute experimental autoimmune encephalomyelitis rat model |
Q48415510 | Apoptosis following peripheral sensory deafferentation in the olfactory bulb of adult zebrafish. |
Q36895340 | Apoptosis in experimental myocardial infarction in situ and in the perfused heart in vitro |
Q74170837 | Apoptosis in neural development and disease |
Q34186312 | Apoptosis in neurodegenerative disorders |
Q33197559 | Apoptosis of auditory neurons following central process injury |
Q35812767 | Apoptosis of neurons and oligodendrocytes in the spinal cord of spinal hyperostotic mouse (twy/twy): possible pathomechanism of human cervical compressive myelopathy |
Q90666267 | Applying univariate vs. multivariate statistics to investigate therapeutic efficacy in (pre)clinical trials: A Monte Carlo simulation study on the example of a controlled preclinical neurotrauma trial |
Q64259142 | Association between plasma macrophage migration inhibitor factor and deep vein thrombosis in patients with spinal cord injuries |
Q42368091 | Automatic quantitative analysis of experimental primary and secondary retinal neurodegeneration: implications for optic neuropathies |
Q40548771 | Autonomic and motor neuron death is progressive and parallel in a lumbosacral ventral root avulsion model of cauda equina injury |
Q27027911 | Axon regeneration and exercise-dependent plasticity after spinal cord injury |
Q35749193 | Axonal injury heralds virus-induced demyelination. |
Q35909149 | Axonal thinning and extensive remyelination without chronic demyelination in spinal injured rats |
Q78094928 | Basic fibroblast growth factor increases long-term survival of spinal motor neurons and improves respiratory function after experimental spinal cord injury |
Q48331439 | Beneficial effects of αB-crystallin in spinal cord contusion injury. |
Q26780494 | Biomaterial Approaches to Enhancing Neurorestoration after Spinal Cord Injury: Strategies for Overcoming Inherent Biological Obstacles |
Q39174919 | CCR5 blockade promotes M2 macrophage activation and improves locomotor recovery after spinal cord injury in mice |
Q36644531 | CM101-mediated recovery of walking ability in adult mice paralyzed by spinal cord injury |
Q73011088 | Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury |
Q48203897 | Calcium ionophores can induce either apoptosis or necrosis in cultured cortical neurons |
Q73371207 | Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors |
Q44499286 | Caspase inhibition attenuates transection-induced oligodendrocyte apoptosis in the developing chick spinal cord |
Q40903065 | Caspases mediate C2-ceramide-induced apoptosis of the human oligodendroglial cell line, MO3.13. |
Q37006491 | Cell death after spinal cord injury is exacerbated by rapid TNF alpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane |
Q34098206 | Cell death and plasticity after experimental spinal cord injury |
Q35002711 | Cell death in models of spinal cord injury |
Q45288423 | Cell proliferation and replacement following contusive spinal cord injury |
Q39261219 | Cell transplantation therapy for spinal cord injury. |
Q48109065 | Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. |
Q36045383 | Cellular transplantation strategies for spinal cord injury and translational neurobiology |
Q90732168 | Central Nervous System Remyelination: Roles of Glia and Innate Immune Cells |
Q45714347 | Cerebrospinal fluid tau protein as a biomarker for severity of spinal cord injury in dogs with intervertebral disc herniation |
Q33678177 | Changes in NG2 cells and oligodendrocytes in a new model of intraspinal hemorrhage |
Q36754698 | Characterizing phospholipase A2-induced spinal cord injury-a comparison with contusive spinal cord injury in adult rats. |
Q21284516 | Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair |
Q40480193 | Chronic alterations in the cellular composition of spinal cord white matter following contusion injury. |
Q33632329 | Chronic expression of PPAR-delta by oligodendrocyte lineage cells in the injured rat spinal cord |
Q34989976 | Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats. |
Q64985709 | Clinical correlates of high cervical fractional anisotropy in acute cervical spinal cord injury. |
Q37425265 | Combination of methylprednisolone and rosiglitazone promotes recovery of neurological function after spinal cord injury |
Q37985448 | Combination therapies in the CNS: engineering the environment |
Q37281196 | Control of demyelination for recovery of spinal cord injury |
Q26824854 | Current and future medical therapeutic strategies for the functional repair of spinal cord injury |
Q35572698 | Current developments in spinal cord injury research |
Q34235128 | Cycling exercise affects the expression of apoptosis-associated microRNAs after spinal cord injury in rats |
Q35061098 | Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injury |
Q36576063 | Delayed Imatinib Treatment for Acute Spinal Cord Injury: Functional Recovery and Serum Biomarkers |
Q46115477 | Delayed death of identified reticulospinal neurons after spinal cord injury in lampreys |
Q98181135 | Delayed short-term tamoxifen treatment does not promote remyelination or neuron sparing after spinal cord injury |
Q34506743 | Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. |
Q51134043 | Deletion of mammalian sterile 20-like kinase 1 attenuates neuronal loss and improves locomotor function in a mouse model of spinal cord trauma. |
Q36780340 | Demyelinating diseases and potential repair strategies |
Q27333128 | Derivation of multivariate syndromic outcome metrics for consistent testing across multiple models of cervical spinal cord injury in rats |
Q40075520 | Development of a cell transducible RhoA inhibitor TAT-C3 transferase and its encapsulation in biocompatible microspheres to promote survival and enhance regeneration of severed neurons |
Q42974441 | Developmental stage of oligodendrocytes determines their response to activated microglia in vitro. |
Q48973206 | Dexamethasone reduces the expression of p75 neurotrophin receptor and apoptosis in contused spinal cord. |
Q60923226 | Differences in neuroplasticity after spinal cord injury in varying animal models and humans |
Q50521439 | Differential and cooperative actions of Olig1 and Olig2 transcription factors on immature proliferating cells after contusive spinal cord injury. |
Q34569222 | Differential effects of injury severity on cognition and cellular pathology after contusive brain trauma in the immature rat |
Q35709144 | Differential expression of sPLA2 following spinal cord injury and a functional role for sPLA2-IIA in mediating oligodendrocyte death |
Q41530019 | Diffusion Kurtosis Imaging and Pathology in Spinal Cord Ischemia/Reperfusion Injury in Rabbits: A Case-Control Study. |
Q35754938 | Docosahexaenoic acid pretreatment confers protection and functional improvements after acute spinal cord injury in adult rats. |
Q38809907 | Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials? |
Q55009229 | Dorsal and ventral horn atrophy is associated with clinical outcome after spinal cord injury. |
Q37375245 | Dose-dependent anti-inflammatory and neuroprotective effects of an ανβ3 integrin-binding peptide |
Q38311700 | E-64-d prevents both calpain upregulation and apoptosis in the lesion and penumbra following spinal cord injury in rats |
Q33400432 | EGb761 protects hydrogen peroxide-induced death of spinal cord neurons through inhibition of intracellular ROS production and modulation of apoptotic regulating genes |
Q35356878 | Edaravone combined with Schwann cell transplantation may repair spinal cord injury in rats |
Q42368455 | Editorial: Karolinska Institutet 200-Year Anniversary Symposium on Injuries to the Spinal Cord and Peripheral Nervous System-An Update on Recent Advances in Regenerative Neuroscience |
Q36317365 | Effect of hyperbaric oxygen on MMP9/2 expression and motor function in rats with spinal cord injury |
Q90175460 | Effect of the combination of high-frequency repetitive magnetic stimulation and neurotropin on injured sciatic nerve regeneration in rats |
Q52679112 | Effects of Dietary Vitamin E Supplementation in Bladder Function and Spasticity during Spinal Cord Injury. |
Q34610550 | Effects of axon degeneration on oligodendrocyte lineage cells: dorsal rhizotomy evokes a repair response while axon degeneration rostral to spinal contusion induces both repair and apoptosis. |
Q42840267 | Effects of dantrolene on apoptosis and immunohistochemical expression of NeuN in the spinal cord after traumatic injury in rats |
Q90361816 | Effects of decompression joint Governor Vessel electro-acupuncture on rats with acute upper cervical spinal cord injury |
Q74339233 | Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury |
Q51450827 | Effects of the sodium channel blocker tetrodotoxin on acute white matter pathology after experimental contusive spinal cord injury. |
Q45933860 | Endogenous neurogenesis replaces oligodendrocytes and astrocytes after primate spinal cord injury. |
Q28506238 | Enhanced Oligodendrocyte Survival after Spinal Cord Injury in Bax-Deficient Mice and Mice with Delayed Wallerian Degeneration |
Q27329888 | EphB3 receptors function as dependence receptors to mediate oligodendrocyte cell death following contusive spinal cord injury |
Q34149632 | Establishing a model spinal cord injury in the African green monkey for the preclinical evaluation of biodegradable polymer scaffolds seeded with human neural stem cells |
Q91045333 | Evaluation of hyperbaric oxygen therapy for spinal cord injury in rats with different treatment course using diffusion tensor imaging |
Q38417759 | Exercise after spinal cord injury as an agent for neuroprotection, regeneration and rehabilitation |
Q47812559 | Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period. |
Q80182894 | Expression of CAPON after spinal cord injury in rats |
Q37363445 | Extensive apoptosis in a case of intractable infantile status epilepticus |
Q48453039 | Extensive degradation of myelin basic protein isoforms by calpain following traumatic brain injury. |
Q83011995 | Fas and FasL expression in the spinal cord following cord hemisection in the monkey |
Q60711548 | Fas receptor and neuronal cell death after spinal cord ischemia |
Q35574725 | Fas/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application |
Q34338454 | Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report |
Q89964158 | Fibroblast Growth Factor 22 Inhibits ER Stress-Induced Apoptosis and Improves Recovery of Spinal Cord Injury |
Q48771532 | Fluororuby as a marker for detection of acute axonal injury in rat spinal cord. |
Q35540600 | Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury |
Q38366783 | From demyelination to remyelination: the road toward therapies for spinal cord injury |
Q33210277 | Frozen-section fluorescence microscopy and stereology in the quantification of neuronal death within dorsal root ganglia |
Q33618981 | Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells |
Q74154142 | Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury |
Q50551632 | G-CSF promotes autophagy and reduces neural tissue damage after spinal cord injury in mice. |
Q35727006 | G-protein-coupled receptor 30-mediated antiapoptotic effect of estrogen on spinal motor neurons following injury and its underlying mechanisms |
Q43599090 | GM-CSF protects rat photoreceptors from death by activating the SRC-dependent signalling and elevating anti-apoptotic factors and neurotrophins |
Q35134411 | GM-CSF reduces expression of chondroitin sulfate proteoglycan (CSPG) core proteins in TGF-β-treated primary astrocytes |
Q34839934 | Gap junction proteins and their role in spinal cord injury |
Q46932004 | Genetic ablation of receptor for advanced glycation end products promotes functional recovery in mouse model of spinal cord injury |
Q30309882 | Genetic influences on secondary degeneration and wound healing following spinal cord injury in various strains of mice |
Q28072659 | Genetics Underlying an Individualized Approach to Adult Spinal Disorders |
Q52927068 | Ginsenoside Rg3 Improves Recovery from Spinal Cord Injury in Rats via Suppression of Neuronal Apoptosis, Pro-Inflammatory Mediators, and Microglial Activation. |
Q88574916 | Glial Cells Shape Pathology and Repair After Spinal Cord Injury |
Q37163112 | Glial reactions and degeneration of myelinated processes in spinal cord gray matter in chronic experimental autoimmune encephalomyelitis |
Q34125992 | Glucocorticoid protection of oligodendrocytes against excitotoxin involving hypoxia-inducible factor-1alpha in a cell-type-specific manner. |
Q44435580 | Glutamate enhances caspase-3 immunoreactivity in cultured spinal cord neurons of newborn rats |
Q28575846 | Glutamate-induced losses of oligodendrocytes and neurons and activation of caspase-3 in the rat spinal cord |
Q73320627 | Granule neuron DNA damage following deafferentation in adult rats cerebellar cortex: a lesion model |
Q34500255 | Granulocyte colony-stimulating factor (G-CSF) protects oligodendrocyte and promotes hindlimb functional recovery after spinal cord injury in rats |
Q36131065 | Guanosine reduces apoptosis and inflammation associated with restoration of function in rats with acute spinal cord injury |
Q43077928 | HMGB1 as a therapeutic target in spinal cord injury: A hypothesis for novel therapy development. |
Q36947789 | HMGB1 protein does not mediate the inflammatory response in spontaneous spinal cord regeneration: a hint for CNS regeneration |
Q33634585 | HSYA alleviates secondary neuronal death through attenuating oxidative stress, inflammatory response, and neural apoptosis in SD rat spinal cord compression injury |
Q90845265 | Heterogeneous fate choice of genetically modulated adult neural stem cells in gray and white matter of the central nervous system |
Q55953987 | Human brain plasticity: an emerging view of the multiple substrates and mechanisms that cause cortical changes and related sensory dysfunctions after injuries of sensory inputs from the body |
Q36243098 | Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. |
Q28250167 | Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury |
Q35007166 | Hydrogen peroxide administered into the rat spinal cord at the level elevated by contusion spinal cord injury oxidizes proteins, DNA and membrane phospholipids, and induces cell death: attenuation by a metalloporphyrin |
Q41147258 | Hydrogen-rich saline injection into the subarachnoid cavity within 2 weeks promotes recovery after acute spinal cord injury |
Q36222821 | Hyperbaric oxygen therapy combined with Schwann cell transplantation promotes spinal cord injury recovery. |
Q35046949 | Hyperbaric oxygen therapy improves local microenvironment after spinal cord injury |
Q41637172 | Hyperbaric oxygen therapy reduces apoptosis after spinal cord injury in rats |
Q84968307 | Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury |
Q90441702 | Hypothermic treatment after computer-controlled compression in minipig: A preliminary report on the effect of epidural vs. direct spinal cord cooling |
Q37474587 | IKVAV-linked cell membrane-spanning peptide treatment induces neuronal reactivation following spinal cord injury. |
Q37692985 | Imaging techniques in spinal cord injury. |
Q37286236 | Immunization with a neural-derived peptide protects the spinal cord from apoptosis after traumatic injury |
Q34098222 | Immunological regulation of neuronal degeneration and regeneration in the injured spinal cord |
Q51989979 | Immunomodulatory effect of the purine nucleoside inosine following spinal cord contusion injury in rat. |
Q28575854 | Increased expression of a proline-rich Akt substrate (PRAS40) in human copper/zinc-superoxide dismutase transgenic rats protects motor neurons from death after spinal cord injury |
Q35993239 | Inflammation & apoptosis in spinal cord injury |
Q35390301 | Inhibition of Apoptosis and Efficacy of Pan Caspase Inhibitor, Q-VD-OPh, in Models of Human Disease |
Q28189050 | Inhibition of axotomy-induced neuronal apoptosis by extracellular delivery of a Bcl-XL fusion protein |
Q56980099 | Integrated systems analysis reveals conserved gene networks underlying response to spinal cord injury |
Q90608272 | Intrathecal transplantation of autologous bone marrow mononuclear cells in patients with sub-acute and chronic spinal cord injury: An open-label study |
Q38079579 | Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. |
Q46369698 | Leukemia inhibitory factor promotes oligodendrocyte survival after spinal cord injury |
Q46666867 | Liraglutide activates autophagy via GLP-1R to improve functional recovery after spinal cord injury |
Q51542251 | Local blockade of sodium channels by tetrodotoxin ameliorates tissue loss and long-term functional deficits resulting from experimental spinal cord injury. |
Q48038011 | Local delivery of minocycline from metal ion-assisted self-assembled complexes promotes neuroprotection and functional recovery after spinal cord injury |
Q58454971 | Locomotor recovery following contusive spinal cord injury does not require oligodendrocyte remyelination |
Q33624404 | Long Coding RNA XIST Contributes to Neuronal Apoptosis through the Downregulation of AKT Phosphorylation and Is Negatively Regulated by miR-494 in Rat Spinal Cord Injury |
Q36896476 | Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. |
Q83324470 | Long-term changes in spinal cord evoked potentials after compression spinal cord injury in the rat |
Q34385587 | Long-term survival, axonal growth-promotion, and myelination of Schwann cells grafted into contused spinal cord in adult rats |
Q48932717 | Mash1 and neurogenin 2 enhance survival and differentiation of neural precursor cells after transplantation to rat brains via distinct modes of action. |
Q26774921 | Mechanical and cellular processes driving cervical myelopathy |
Q88574913 | Mesenchymal Stem Cell-Macrophage Choreography Supporting Spinal Cord Repair |
Q36157474 | Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats |
Q36059599 | Methylprednisolone exerts neuroprotective effects by regulating autophagy and apoptosis |
Q37357140 | Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury |
Q37601818 | MicroRNA dysregulation in spinal cord injury: causes, consequences and therapeutics. |
Q27305161 | MicroRNA dysregulation in the spinal cord following traumatic injury |
Q92714832 | MicroRNA-23b attenuates the H2O2-induced injury of microglial cells via TAB3/NF-κB signaling pathway |
Q53180449 | Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury. |
Q41831282 | Microglial inhibitory factor (MIF/TKP) mitigates secondary damage following spinal cord injury |
Q48638931 | Mild traumatic brain injury induces apoptotic cell death in the cortex that is preceded by decreases in cellular Bcl-2 immunoreactivity. |
Q48103125 | Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. |
Q36853743 | Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury |
Q33198766 | Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. |
Q34982284 | Miracles and molecules--progress in spinal cord repair |
Q35737528 | Molecular Architecture of Spinal Cord Injury Protein Interaction Network. |
Q35059282 | Molecular Mechanisms Underlying Cell Death in Spinal Networks in Relation to Locomotor Activity After Acute Injury in vitro |
Q35580651 | Molecular biology of cervical myelopathy and spinal cord injury: role of oligodendrocyte apoptosis |
Q36216362 | Molecular targets in spinal cord injury |
Q29249010 | Motoneuron Death after Human Spinal Cord Injury |
Q91987422 | Motor Recovery after Transplantation of Bone Marrow Mesenchymal Stem Cells in Rat Models of Spinal Cord Injury |
Q36729321 | Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential |
Q26797407 | Myelin damage and repair in pathologic CNS: challenges and prospects |
Q38332152 | Myelin gene expression after experimental contusive spinal cord injury. |
Q50477254 | Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression. |
Q48325850 | Myelin plasticity, neural activity, and traumatic neural injury |
Q92837765 | Myelin status and oligodendrocyte lineage cells over time after spinal cord injury: What do we know and what still needs to be unwrapped? |
Q48172017 | Myelinogenic Plasticity of Oligodendrocyte Precursor Cells following Spinal Cord Contusion Injury |
Q37190678 | N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain |
Q48595101 | Naringin treatment improves functional recovery by increasing BDNF and VEGF expression, inhibiting neuronal apoptosis after spinal cord injury. |
Q38212924 | Natural polyphenols and spinal cord injury |
Q36499220 | Necroptosis, a novel type of programmed cell death, contributes to early neural cells damage after spinal cord injury in adult mice |
Q89596868 | Neonatal hydrocephalus leads to white matter neuroinflammation and injury in the corpus callosum of Ccdc39 hydrocephalic mice |
Q60684621 | Nerve Growth Factor Protects Oligodendrocytes from Tumor Necrosis Factor-α-induced Injury through Akt-mediated Signaling Mechanisms |
Q81688430 | Neural plasticity after spinal cord injury |
Q39906289 | Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury. |
Q34172960 | Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials |
Q79936904 | Neurocyte apoptosis and expressions of caspase-3 and Fas after spinal cord injury and their implication in rats |
Q40207513 | Neuropathological Characteristics of Brachial Plexus Avulsion Injury With and Without Concomitant Spinal Cord Injury. |
Q36045235 | Neuroprotection and acute spinal cord injury: a reappraisal |
Q34975626 | Neuroprotection and its molecular mechanism following spinal cord injury |
Q49269113 | Neuroprotection by chitosan nanoparticles in oxidative stress-mediated injury. |
Q92974052 | Neuroprotection, Recovery of Function and Endogenous Neurogenesis in Traumatic Spinal Cord Injury Following Transplantation of Activated Adipose Tissue |
Q47814324 | Neuroprotective Activities of Saffron and Crocin |
Q37963878 | Neuroprotective Mechanisms of PPARδ: Modulation of Oxidative Stress and Inflammatory Processes |
Q37523905 | Neuroprotective effects of perflurocarbon (oxycyte) after contusive spinal cord injury |
Q47892533 | Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. |
Q40526881 | Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. |
Q35332802 | New Prophylactic and Therapeutic Strategies for Spinal Cord Injury |
Q78094837 | Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling |
Q49105945 | Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury. |
Q37074091 | No evidence for chronic demyelination in spared axons after spinal cord injury in a mouse |
Q36540686 | OLIGODENDROCYTE VULNERABILITY FOLLOWING TRAUMATIC BRAIN INJURY IN RATS: EFFECT OF MODERATE HYPOTHERMIA. |
Q34238105 | Olfactory ensheathing cells - another miracle cure for spinal cord injury? |
Q35006477 | Oligodendrocyte fate after spinal cord injury |
Q47233535 | Oligodendrocyte precursor cell transplantation promotes functional recovery following contusive spinal cord injury in rats and is associated with altered microRNA expression |
Q36469769 | Oligodendrocyte vulnerability following traumatic brain injury in rats |
Q59330262 | Oligodendroglia Are Particularly Vulnerable to Oxidative Damage After Neurotrauma In Vivo |
Q57839844 | Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat |
Q48938399 | Oligodendroglial cell death with DNA fragmentation in the white matter under chronic cerebral hypoperfusion: comparison between normotensive and spontaneously hypertensive rats. |
Q36108225 | Opposite regulation of oligodendrocyte apoptosis by JNK3 and Pin1 after spinal cord injury |
Q39805023 | Optimal location and time for neural stem cell transplantation into transected rat spinal cord |
Q37008474 | Oral administration of a small molecule targeted to block proNGF binding to p75 promotes myelin sparing and functional recovery after spinal cord injury |
Q40465118 | Overexpression of XIAP inhibits apoptotic cell death in an oligodendroglial cell line. |
Q51335031 | PRDM5 Expression and Essential Role After Acute Spinal Cord Injury in Adult Rat. |
Q33748155 | PTEN inhibitor bisperoxovanadium protects oligodendrocytes and myelin and prevents neuronal atrophy in adult rats following cervical hemicontusive spinal cord injury |
Q33915855 | Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. |
Q33805235 | Pathology dynamics predict spinal cord injury therapeutic success |
Q73336402 | Peripheral nerve injury induces endoneurial expression of IFN-gamma, IL-10 and TNF-alpha mRNA |
Q34619889 | Peripheral noxious stimulation reduces withdrawal threshold to mechanical stimuli after spinal cord injury: role of tumor necrosis factor alpha and apoptosis |
Q44283543 | Peroxynitrite generated in the rat spinal cord induces apoptotic cell death and activates caspase-3. |
Q52674804 | Pharmacokinetics and safety of oral glyburide in dogs with acute spinal cord injury. |
Q37686358 | Phospholipase A2 and its molecular mechanism after spinal cord injury |
Q83307993 | Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study |
Q35983143 | Photothrombosis-induced Focal Ischemia as a Model of Spinal Cord Injury in Mice. |
Q50501021 | Platelet-derived growth factor-responsive neural precursors give rise to myelinating oligodendrocytes after transplantation into the spinal cords of contused rats and dysmyelinated mice. |
Q38124780 | Polyethylene glycol repairs membrane damage and enhances functional recovery: a tissue engineering approach to spinal cord injury |
Q35157997 | Post-traumatic inflammation following spinal cord injury |
Q75233280 | Post-traumatic moderate systemic hypothermia reduces TUNEL positive cells following spinal cord injury in rat |
Q24671661 | Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease |
Q37134018 | Potential Therapeutic Targets for PPARgamma after Spinal Cord Injury |
Q55480248 | Potential Utility of Retinal Imaging for Alzheimer’s Disease: A Review. |
Q41716847 | Potential neuroprotective therapy for glaucomatous optic neuropathy |
Q33187322 | Primary cortical motor neurons undergo apoptosis after axotomizing spinal cord injury |
Q28574864 | ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury |
Q36873715 | Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies |
Q33944968 | Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. |
Q48256973 | Prominent oligodendrocyte genesis along the border of spinal contusion lesions. |
Q35092261 | Prospects for antiapoptotic drug therapy of neurodegenerative diseases |
Q44107673 | Protective effects of oral creatine supplementation on spinal cord injury in rats. |
Q33829332 | Proteomic and phosphoproteomic analyses of the soluble fraction following acute spinal cord contusion in rats |
Q48455614 | Purification of a multipotent antideath activity from bovine liver and its identification as arginase: nitric oxide-independent inhibition of neuronal apoptosis. |
Q58766273 | Quantitative MRI of rostral spinal cord and brain regions is predictive of functional recovery in acute spinal cord injury |
Q90119612 | Quantitative profiling of regional protein expression in rat retina after partial optic nerve transection using fluorescence difference two‑dimensional gel electrophoresis |
Q43075178 | Quercetin attenuates inflammatory processes after spinal cord injury in an animal model |
Q28071816 | Rat models of spinal cord injury: from pathology to potential therapies |
Q28248202 | Reactive astrocytes protect tissue and preserve function after spinal cord injury |
Q36542958 | Reactive astrocytes undergo M1 microglia/macrohpages-induced necroptosis in spinal cord injury |
Q38234624 | Receptor for advanced glycation end products (RAGE) and its ligands: focus on spinal cord injury |
Q51215749 | Regeneration of the rat spinal cord after thoracic segmentectomy: restoration of the anatomical integrity of the spinal cord. |
Q36996629 | Repetitive magnetic stimulation affects the microenvironment of nerve regeneration and evoked potentials after spinal cord injury |
Q88532210 | RhoA activation in axotomy-induced neuronal death |
Q35209243 | RhoA-inhibiting NSAIDs promote axonal myelination after spinal cord injury |
Q52581900 | Role of Caspase-8 and Fas in Cell Death After Spinal Cord Injury. |
Q38595955 | Role of Diffusion Tensor MR Imaging in Degenerative Cervical Spine Disease: a Review of the Literature |
Q36864853 | Rolipram attenuates acute oligodendrocyte death in the adult rat ventrolateral funiculus following contusive cervical spinal cord injury |
Q36790871 | Salvianolic acid B protects the myelin sheath around injured spinal cord axons |
Q34471414 | Secondary degeneration reduced by inosine after spinal cord injury in rats |
Q35083357 | Secretome analysis of human oligodendrocytes derived from neural stem cells |
Q24646208 | Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury |
Q40590302 | Sequential loss of myelin proteins during Wallerian degeneration in the rat spinal cord |
Q90386364 | Serial plasma DNA levels as predictors of outcome in patients with acute traumatic cervical spinal cord injury |
Q33594010 | Serial serum leukocyte apoptosis levels as predictors of outcome in acute traumatic brain injury |
Q36627516 | Significant correlation between cerebrospinal fluid nitric oxide concentrations and neurologic prognosis in incomplete cervical cord injury. |
Q34679913 | Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. |
Q80548042 | Spatiotemporal expression of Dexras1 after spinal cord transection in rats |
Q47931237 | Spatiotemporal patterns and essential role of TNF receptor-associated factor 5 expression after rat spinal cord Injury |
Q27026103 | Sphingolipids in spinal cord injury |
Q35002788 | Spinal cord contusion models |
Q43170523 | Spinal cord decompression reduces rat neural cell apoptosis secondary to spinal cord injury |
Q77403293 | Spinal cord injury in the rat |
Q46943223 | Spinal cord injury is accompanied by chronic progressive demyelination. |
Q48291049 | Spinal cord injury: bridging the lesion and the role of neurotrophic factors in repair. |
Q37765474 | Stem cell therapies for spinal cord injury |
Q46158053 | Stem cells downregulate the elevated levels of tissue plasminogen activator in rats after spinal cord injury |
Q49940089 | Stem cells for spinal cord injuries bearing translational potential. |
Q34482689 | Stem cells for spinal cord regeneration: Current status |
Q34098199 | Strategies for spinal cord injury repair. |
Q38679487 | Subacute Posttraumatic Ascending Myelopathy After an Incomplete Spinal Cord Injury from a Gunshot Wound to the Spine: Case Report and Review of the Literature |
Q91667640 | Subacute Traumatic Ascending Myelopathy in a 28-Year-Old Man: A Rare Case |
Q30240006 | Subacute posttraumatic ascending myelopathy: a literature review |
Q34385981 | Survival, Differentiation, and Migration of High-Purity Mouse Embryonic Stem Cell-derived Progenitor Motor Neurons in Fibrin Scaffolds after Sub-Acute Spinal Cord Injury |
Q28741573 | Syndromics: a bioinformatics approach for neurotrauma research |
Q43630109 | Synthesis and evaluation of a difluoromethylene analogue of sphingomyelin as an inhibitor of sphingomyelinase |
Q27001059 | T cells in the central nervous system: messengers of destruction or purveyors of protection? |
Q36985378 | TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord |
Q36415334 | TNFalpha-induced AMPA-receptor trafficking in CNS neurons; relevance to excitotoxicity? |
Q81677601 | Targeted expression of anti-apoptotic protein p35 in oligodendrocytes reduces delayed demyelination and functional impairment after spinal cord injury |
Q48597439 | Tauroursodeoxycholic acid alleviates secondary injury in the spinal cord via up-regulation of CIBZ gene. |
Q44538522 | Temporal and spatial distribution of activated caspase-3 after subdural kainic acid infusions in rat spinal cord |
Q48226697 | Temporal-spatial dynamics in oligodendrocyte and glial progenitor cell numbers throughout ventrolateral white matter following contusion spinal cord injury |
Q36499206 | Temporospatial expression of fibulin-1 after acute spinal cord injury in rats |
Q41575599 | The Effects of Difumarate Salt S-15176 after Spinal Cord Injury in Rats |
Q37618338 | The Function of FGFR1 Signalling in the Spinal Cord: Therapeutic Approaches Using FGFR1 Ligands after Spinal Cord Injury |
Q34442409 | The JNK- and AKT/GSK3β- signaling pathways converge to regulate Puma induction and neuronal apoptosis induced by trophic factor deprivation |
Q27863415 | The LTB4-BLT1 axis mediates neutrophil infiltration and secondary injury in experimental spinal cord injury |
Q37781898 | The Pathogenesis and Treatment of Acute Spinal Cord Injuries in Dogs |
Q38598334 | The Role of Therapeutic Hypothermia After Traumatic Spinal Cord Injury--A Systematic Review |
Q37523956 | The cancer drug tamoxifen: a potential therapeutic treatment for spinal cord injury |
Q57212868 | The combined effect of granulocyte-colony stimulating factor (G-CSF) treatment and exercise in rats with spinal cord injury |
Q42376420 | The combined strategy of mesenchymal stem cells and tissue-engineered scaffolds for spinal cord injury regeneration |
Q33685823 | The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration |
Q36735140 | The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelination. |
Q92745530 | The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury |
Q37118012 | The importance of NAD in multiple sclerosis |
Q27320717 | The multifaceted effects of agmatine on functional recovery after spinal cord injury through Modulations of BMP-2/4/7 expressions in neurons and glial cells |
Q36317961 | The potential for cellular therapy combined with growth factors in spinal cord injury |
Q34745966 | The prevalence and phenotype of activated microglia/macrophages within the spinal cord of the hyperostotic mouse (twy/twy) changes in response to chronic progressive spinal cord compression: implications for human cervical compressive myelopathy |
Q36520580 | The reactions and role of NG2 glia in spinal cord injury |
Q38061012 | The retina as a window to the brain-from eye research to CNS disorders |
Q48416693 | The role of RhoA in retrograde neuronal death and axon regeneration after spinal cord injury. |
Q37433757 | The role of inducible nitric oxide synthase following spinal cord injury in rat. |
Q47640776 | The role of the miR-99b-5p/mTOR signaling pathway in neuroregeneration in mice following spinal cord injury |
Q48305269 | The role of voltage-gated Ca2+ channels in anoxic injury of spinal cord white matter |
Q35044629 | The temporal and spatial profiles of cell loss following experimental spinal cord injury: effect of antioxidant therapy on cell death and functional recovery. |
Q21089854 | The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injury |
Q34118301 | Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration. |
Q26749447 | Therapeutic Effects of Traditional Chinese Medicine on Spinal Cord Injury: A Promising Supplementary Treatment in Future |
Q36542728 | Therapeutic interventions after spinal cord injury. |
Q33933379 | Thoracic rat spinal cord contusion injury induces remote spinal gliogenesis but not neurogenesis or gliogenesis in the brain |
Q51736036 | Three dimensional electron microscopy reveals changing axonal and myelin morphology along normal and partially injured optic nerves. |
Q35116558 | Tight squeeze, slow burn: inflammation and the aetiology of cervical myelopathy |
Q35102824 | To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways |
Q50940964 | Tolerability and efficacy of erythropoietin (EPO) treatment in traumatic spinal cord injury: a preliminary randomized comparative trial vs. methylprednisolone (MP). |
Q27306821 | Topiramate treatment is neuroprotective and reduces oligodendrocyte loss after cervical spinal cord injury |
Q34004263 | Topography of neuron loss in the retinal ganglion cell layer in human glaucoma |
Q31004909 | Topological data analysis for discovery in preclinical spinal cord injury and traumatic brain injury. |
Q42200227 | Transduction efficiency of neurons and glial cells by AAV-1, -5, -9, -rh10 and -hu11 serotypes in rat spinal cord following contusion injury |
Q37712579 | Transplantation of PDGF-AA-Overexpressing Oligodendrocyte Precursor Cells Promotes Recovery in Rat Following Spinal Cord Injury |
Q33720720 | Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury. |
Q30490845 | Transplantation of human neural stem cells transduced with Olig2 transcription factor improves locomotor recovery and enhances myelination in the white matter of rat spinal cord following contusive injury |
Q37763613 | Transplantation of umbilical cord blood stem cells for treating spinal cord injury |
Q37576550 | Transplantation-mediated strategies to promote axonal regeneration following spinal cord injury. |
Q64061191 | Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms |
Q38315209 | Traumatic injury induces differential expression of cell death genes in organotypic brain slice cultures determined by complementary DNA array hybridization |
Q43807452 | Traumatic injury-induced BMP7 expression in the adult rat spinal cord |
Q37574857 | Treadmill exercise reduces spinal cord injury-induced apoptosis by activating the PI3K/Akt pathway in rats |
Q74411614 | Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury |
Q36312720 | Umbilical cord blood stem cell mediated downregulation of fas improves functional recovery of rats after spinal cord injury |
Q28078778 | Understanding the NG2 Glial Scar after Spinal Cord Injury |
Q38713422 | Unique spectral signatures of the nucleic acid dye acridine orange can distinguish cell death by apoptosis and necroptosis. |
Q78709741 | Upregulation of phospholipase D1 in the spinal cords of rats with clip compression injury |
Q47961640 | Using Retinal Imaging to Study Dementia |
Q79080347 | Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury |
Q44554982 | Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury |
Q35232779 | Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury |
Q34939468 | White matter changes linked to visual recovery after nerve decompression |
Q37876560 | Will stem cell therapies be safe and effective for treating spinal cord injuries? |
Q41233374 | Zbtb38 is a novel target for spinal cord injury. |
Q27009439 | microRNAs in spinal cord injury: potential roles and therapeutic implications |
Q45329398 | p53- and Bax-mediated apoptosis in injured rat spinal cord |
Q33971766 | p75 neurotrophin receptor signaling: mechanisms for neurotrophic modulation of cell stress? |
Search more.